These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 3097131

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Signals involved in T cell activation. II. Distinct roles of intact accessory cells, phorbol esters, and interleukin 1 in activation and cell cycle progression of resting T lymphocytes.
    Davis L, Lipsky PE.
    J Immunol; 1986 May 15; 136(10):3588-96. PubMed ID: 3486215
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Specific inhibition of OKT3-driven T-cell mitogenesis by an anti HLA-class I monoclonal antibody.
    Beckman I, Xiaoning X, Bradley J.
    Immunology; 1988 Nov 15; 65(3):373-8. PubMed ID: 3264808
    [Abstract] [Full Text] [Related]

  • 9. T4 cell activation by immobilized phytohemagglutinin: differential capacity to induce IL-2 responsiveness and IL-2 production.
    Vine JB, Geppert TD, Lipsky PE.
    J Immunol; 1988 Oct 15; 141(8):2593-600. PubMed ID: 2844904
    [Abstract] [Full Text] [Related]

  • 10. Valency of CD3 binding and internalization of the CD3 cell-surface complex control T cell responses to second signals: distinction between effects on protein kinase C, cytoplasmic free calcium, and proliferation.
    Ledbetter JA, June CH, Martin PJ, Spooner CE, Hansen JA, Meier KE.
    J Immunol; 1986 Jun 01; 136(11):3945-52. PubMed ID: 3084650
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Evidence for IL-2 independent proliferation in human T cells.
    Laing TJ, Weiss A.
    J Immunol; 1988 Feb 15; 140(4):1056-62. PubMed ID: 2830333
    [Abstract] [Full Text] [Related]

  • 14. Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation.
    de Waal Malefyt R, Yssel H, de Vries JE.
    J Immunol; 1993 Jun 01; 150(11):4754-65. PubMed ID: 7684412
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Signals involved in T cell activation. I. Phorbol esters enhance responsiveness but cannot replace intact accessory cells in the induction of mitogen-stimulated T cell proliferation.
    Davis L, Lipsky PE.
    J Immunol; 1985 Nov 01; 135(5):2946-52. PubMed ID: 3876369
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of tumor necrosis factor-alpha and IL-1 beta on mitogen-induced T cell activation.
    Hackett RJ, Davis LS, Lipsky PE.
    J Immunol; 1988 Apr 15; 140(8):2639-44. PubMed ID: 2965728
    [Abstract] [Full Text] [Related]

  • 19. The events of primary T cell activation can be staged by use of Sepharose-bound anti-T3 (64.1) monoclonal antibody and purified interleukin 1.
    Williams JM, Deloria D, Hansen JA, Dinarello CA, Loertscher R, Shapiro HM, Strom TB.
    J Immunol; 1985 Oct 15; 135(4):2249-55. PubMed ID: 3928742
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.